Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
21st Annual Drug Discovery Summit

21st Annual Drug Discovery Summit

Categories

Date of beginning

Tuesday, 26 May 2020

Duration

2 days

City

Berlin

Country

Germany

Contact

Guillaume Alonso

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Join over 400 leaders, experts and scientists at the renowned R&D Series, helping to shape the future of drug discovery and development at Oxford Global’s 20th Annual Drug Discovery Summit and 7th Annual Discovery Chemistry and Drug Design Congress, 26th – 27th May 2020, Berlin, Germany. The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion These events form part of the R&D Series EU and are co-located with our 2nd Annual Neuroscience in Discovery and Development Congresses. View the Agenda: https://bit.ly/34wMgmE For more information contact This email address is being protected from spambots. You need JavaScript enabled to view it. or visit the website: https://bit.ly/33r8ULN Go Social: Join our Drug Discovery and Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and join the conversation at #RNDSeries20 On Tuesday May 26, 2020 at 7:30 am (ends Wednesday May 27, 2020 at 5:00 pm) Price: Admission starts from: EUR 390.00 URLs: Brochure: https://go.evvnt.com/566271-0?pid=5569 Tickets: https://go.evvnt.com/566271-1?pid=5569 Speakers: Steve Rees, Vice President Discovery Biology, AstraZeneca R&D Biopharmaceuticals Discovery Sciences, Ulrich A.K. Betz, Vice President Innovation, Department Head Future Insight, Merck KGaA , Thorsten Thormann, Vice President, Research, LEO Pharma , Alex Gouliaev, Vice President, Amgen , Michael R. Myers, Senior Director, LRL - Due Diligence, Eli Lilly and Company , Oliver Rausch, CSO, Storm Therapeutics Venue details: Maritim Hotel Berlin, 26 Stauffenbergstraße, Berlin, Berlin, 10785, Germany